Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Immunol ; 196(1): 328-35, 2016 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-26608923

RESUMO

Hyperlipidemia has been extensively studied in the context of atherosclerosis, whereas the potential health consequences of the opposite extreme, hypolipidemia, remain largely uninvestigated. Circulating lipoproteins are essential carriers of insoluble lipid molecules and are increasingly recognized as innate immune effectors. Importantly, severe hypolipidemia, which may occur with trauma or critical illness, is clinically associated with bacterial pneumonia. To test the hypothesis that circulating lipoproteins are essential for optimal host innate defense in the lung, we used lipoprotein-deficient mice and a mouse model of Staphylococcus aureus pneumonia in which invasive infection requires virulence factor expression controlled by the accessory gene regulator (agr) operon. Activation of agr and subsequent virulence factor expression is inhibited by apolipoprotein B, the structural protein of low-density lipoprotein, which binds and sequesters the secreted agr-signaling peptide (AIP). In this article, we report that lipoprotein deficiency impairs early pulmonary innate defense against S. aureus quorum-sensing-dependent pathogenesis. Specifically, apolipoprotein B levels in the lung early postinfection are significantly reduced with lipoprotein deficiency, coinciding with impaired host control of S. aureus agr-signaling and increased agr-dependent morbidity (weight loss) and inflammation. Given that lipoproteins also inhibit LTA- and LPS-mediated inflammation, these results suggest that hypolipidemia may broadly impact posttrauma pneumonia susceptibility to both Gram-positive and -negative pathogens. Together with previous reports demonstrating that hyperlipidemia also impairs lung innate defense, these results suggest that maintenance of normal serum lipoprotein levels is necessary for optimal host innate defense in the lung.


Assuntos
Proteínas de Bactérias/metabolismo , Hipolipoproteinemias/imunologia , Lipoproteínas LDL/sangue , Pneumonia Estafilocócica/imunologia , Percepção de Quorum/imunologia , Staphylococcus aureus/imunologia , Transativadores/metabolismo , Animais , Apolipoproteínas B/imunologia , Proteínas de Bactérias/genética , Linhagem Celular , Modelos Animais de Doenças , Humanos , Hipolipoproteinemias/genética , Imunidade Inata/imunologia , Lipoproteínas LDL/imunologia , Pulmão/patologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Transdução de Sinais/genética , Transativadores/genética
2.
Heart Vessels ; 27(4): 377-83, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21655904

RESUMO

The aim of this study was to investigate the association between leukocyte subtype counts and hyper-LDL cholesterolemia, hypertriglyceridemia, and hypo-HDL cholesterolemia. Logistic regressions using hyper-LDL cholesterolemia, hypertriglyceridemia, and hypo-HDL cholesterolemia as a dependent variable and total leukocyte, basophil, eosinophil, neutrophil, lymphocyte, and monocyte counts as an independent variable were calculated adjusting for age, body mass index (BMI), high-sensitivity C-reactive protein (hs-CRP), smoking, drinking, and physical activity in apparently healthy Japanese men (1,803) and women (1,150). The odds ratio (OR) of hyper-LDL cholesterolemia for total leukocyte, eosinophil, and lymphocyte counts, the OR of hypertriglyceridemia for total leukocyte, eosinophil, neutrophil, and lymphocyte counts, and the OR of hypo-HDL cholesterolemia for total leukocyte, neutrophil, and lymphocyte counts were significant in men, and the OR of hyper-LDL cholesterolemia, for lymphocyte count, and the OR of hypo-HDL cholesterolemia for eosinophil count were significant in women. Lymphocyte count was significantly associated with hyper-LDL cholesterolemia independently of hs-CRP in apparently healthy Japanese.


Assuntos
Povo Asiático , Proteína C-Reativa/análise , LDL-Colesterol/sangue , Hiperlipoproteinemia Tipo II/sangue , Contagem de Linfócitos , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores/sangue , HDL-Colesterol/sangue , Estudos Transversais , Feminino , Humanos , Hiperlipoproteinemia Tipo II/etnologia , Hiperlipoproteinemia Tipo II/imunologia , Hipertrigliceridemia/sangue , Hipertrigliceridemia/etnologia , Hipertrigliceridemia/imunologia , Hipolipoproteinemias/sangue , Hipolipoproteinemias/etnologia , Hipolipoproteinemias/imunologia , Japão , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Razão de Chances , Valor Preditivo dos Testes , Medição de Risco , Fatores de Risco , Triglicerídeos/sangue , Regulação para Cima , Adulto Jovem
3.
Intensive Care Med ; 35(11): 1877-85, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19669126

RESUMO

OBJECTIVE: Lipoproteins modulate vascular cell function in inflammation. In this study, we analyzed whether plasma concentrations of lipoproteins and apolipoproteins in human sepsis are related to patient survival and the activation of blood monocytes and platelets. DESIGN: Observational study. SETTING: Medical and surgical intensive care units (ICU) of a university hospital. PATIENTS: 151 consecutive patients after sepsis criteria had been met for the first time. INTERVENTIONS: None. MEASUREMENTS: Plasma lipoproteins, apolipoproteins, platelet CD62P-expression, monocyte HLA-DR-expression, SAPS II-scores (Simplified Acute Physiology Score) and 30-day-mortality were recorded. RESULTS: Total cholesterol, high-density-lipoprotein (HDL) and low-density-lipoprotein (LDL) cholesterol, apolipoprotein (apo)-AI and apo-B were all found to be significantly lower in non-survivors than in survivors. In contrast to other (apo)lipoproteins, apo-AI and HDL cholesterol further decreased in non-survivors during the ICU stay. Logistic regression analysis revealed apo-AI to be an independent predictor of 30-day-mortality. A significant inverse correlation was found for apo-AI/HDL-cholesterol and platelet activation. Later in the course of the disease, HLA-DR expression on monocytes correlated positively to apo-AI and apo-CI concentrations and inversely to the apo-E concentration. CONCLUSION: Low apo-AI is independently related to 30-day mortality in human sepsis and the decrease in apo-AI/HDL cholesterol correlates to increased platelet activation. Moreover, changes in apolipoproteins supposed to modulate lipopolysaccharide effects, such as apo-CI and apo-E, correlate to monocyte activation.


Assuntos
Apolipoproteína A-I , Apolipoproteínas B , Lipoproteínas HDL , Monócitos/imunologia , Ativação Plaquetária/imunologia , Sepse , APACHE , Adulto , Idoso , Apolipoproteína A-I/sangue , Apolipoproteína A-I/deficiência , Apolipoproteínas/deficiência , Apolipoproteínas/imunologia , Apolipoproteínas B/sangue , Apolipoproteínas B/deficiência , Colesterol/sangue , Colesterol/deficiência , HDL-Colesterol/sangue , HDL-Colesterol/deficiência , LDL-Colesterol/sangue , Feminino , Alemanha/epidemiologia , Antígenos HLA-DR/sangue , Humanos , Hipolipoproteinemias/sangue , Hipolipoproteinemias/complicações , Hipolipoproteinemias/imunologia , Lipoproteínas HDL/deficiência , Lipoproteínas HDL/imunologia , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Selectina-P/sangue , Valor Preditivo dos Testes , Prognóstico , Estudos Prospectivos , Curva ROC , Sepse/sangue , Sepse/imunologia , Sepse/mortalidade , Estatísticas não Paramétricas , Taxa de Sobrevida
4.
Artigo em Inglês | MEDLINE | ID: mdl-106460

RESUMO

Antibody towards a highly purified LCAT preparation was tested against LCAT-deficient sera by using the technic of immunodiffusion and immunoinhibition. Reaction of identity among normal serum, deficient sera, and purified LCAT was observed in immunodiffusion with two different antibodies obtained from two different goats. When the antibodies were mixed with deficient sera and tested for immunoinhibition of LCAT activity, suggesting that deficient sera contained an enzymatically inactive LCAT. The other antibody preparation showed inhibition of enzyme activity even in antigen excess. It appears that the precipitin lines observed in immunodiffusion do not represent LCAT in serum. In view of the higher titre of antibody in immunoinhibition experiments with this antibody, it remains to be determined whether at lower ratios of antibody to deficient serum, immunoinhibition by the antibody will be abolished in this case too.


Assuntos
Hipolipoproteinemias/imunologia , Deficiência da Lecitina Colesterol Aciltransferase/imunologia , Anticorpos/análise , Antígenos , Humanos , Soros Imunes , Imunodifusão , Técnicas Imunológicas , Fosfatidilcolina-Esterol O-Aciltransferase/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...